Dott. Nicola Gasparetto

Dott. Nicola Gasparetto MD, PhD, FESC, FANMCO. Cardiologo Intensivista. Responsabile U.O.S. Terapia Intensiva Cardiologica
U.O.C.

Cardiologia, Dipartimento Neuro-Cardio-Vascolare, ULSS 2, Ospedale Ca' Foncello

Componente Area Management & Qualità ANMCO

16/09/2025

Your selection of from the latest Intensive Care Medicine Journal issue:

🔹Heterogenous treatment effect of neuromuscular blocking agents for moderate-to-severe ARDS: a post hoc Markov model re-analysis of the ACURASYS trial 👉 https://rdcu.be/eAeeh
🔹Hemodynamic and neurological presentations of invasive meningococcal disease in adults: a nationwide study across 100+ French ICUs 👉 https://rdcu.be/eAxSV
🔹OPEN ACCESS ~ Identifying distinct clusters of ICU survivors by integrating demographic, pre-admission quality of life, and clinical data: a large prospective cohort study 👉 https://rdcu.be/eAeg1
🔹OPEN ACCESS ~ Identification of transcriptomic sepsis endotypes in sub-Saharan Africa: derivation, validation, and global alignment in two Ugandan cohorts 👉 https://rdcu.be/eytKR
🔹OPEN ACCESS ~ Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy 👉 https://rdcu.be/eARwI
🔹Does ability and willingness to use continuous RRT improve patient outcomes? A few answers, plenty of questions and opportunities for research 👉 https://rdcu.be/exidq
🔹Let PEEP do the talking? 👉 https://rdcu.be/extKI
🔹On the tightrope between life and graft: immunosuppression in critically ill solid organ transplant recipients 👉 https://rdcu.be/eBwtQ
🔹Syndromic diagnostics in pneumonia: the quest for impact continues 👉 https://rdcu.be/eykyE
🔹Re-evaluating the impact of mechanical ventilation strategies during cardiac surgery with cardiopulmonary bypass: work in progress 👉 https://rdcu.be/eAd9b
🔹How we use critical care ultrasonography in the management of cardiogenic shock: a strategic game of chess in intensive care 👉 https://rdcu.be/eARuS
🔹OPEN ACCESS ~ Cardiogenic shock syndrome unraveled: understanding the different layers of heterogeneity 👉 https://rdcu.be/ewiQb
🔹Cardiogenic shock: diagnosis, phenotyping and management 👉 https://rdcu.be/eAebs
🔹OPEN ACCESS ~ What measures have been used to explore the outcomes of family members of critically ill patients: a scoping review 👉 https://rdcu.be/eAxQ2
🔹Norepinephrine pharmacolexicology: a chronological review of dose reporting and the implications of salt formulations 👉 https://rdcu.be/eytL5
🔹Extracorporeal life support for adult patients with ARDS 👉 https://rdcu.be/eAeau

Read more articles here! 👉 https://www.springer.com/journal/134

Fantastica equipe, onorato di lavorare ogni giorno con fantastici professionisti!
12/09/2025

Fantastica equipe, onorato di lavorare ogni giorno con fantastici professionisti!

11/09/2025

https://zurl.co/h6cXc Melatonin alone is insufficient for preventing ICU delirium, as highlighted by the DEMEL trial’s findings. Methodological limitations, lack of non-pharmacologic sleep strategies, concurrent sedative use, unvalidated sleep assessments, and physical restraints may have undermined melatonin’s potential benefit. Effective delirium prevention requires a comprehensive, multimodal approach to sleep and circadian care.

11/09/2025

In ANOCA patients, exertional chest pain was linked to worse microvascular function vs resting chest pain.
👉 Endothelium-independent CMD carried significant prognostic impact over 7 years.
https://ow.ly/hCEg50WPz6k

11/09/2025

❌SIM PUB ❌
New research on β-blockers after MI with preserved LVEF (>40%) just presented at ESC2025
A post hoc analysis of the REBOOT trial (n=8,400+) found no difference in short-term (3-month) or recurrent ischaemic events between patients discharged with or without β-blockers, regardless of prior use.
https://ow.ly/Po4U50WOvPg
; ;

01/09/2025

From JAMA: In patients without atrial arrhythmia recurrence after AF ablation, discontinuing oral anticoagulant therapy reduced the composite risk of stroke, systemic embolism, and major bleeding compared with continued therapy.



https://ja.ma/47f2u70

ANMCO 2025. Momento di condivisione di importanti esperienze professionali.
18/05/2025

ANMCO 2025. Momento di condivisione di importanti esperienze professionali.

17/05/2025

Semaglutide (Wegovy) is associated with a 41% reduction in the risk for major adverse cardiovascular events (MACEs) within 6 months of initiation — well before patients achieve substantial weight loss or reach the full 2.4 mg weekly dose — according to new data from the SELECT trial. http://ms.spr.ly/6181SZq2T

13/04/2025

📌🗓️ 𝕊𝔸𝕍𝔼 𝕋ℍ𝔼 𝔻𝔸𝕋𝔼 ‼️
𝐖𝐄𝐁𝐈𝐍𝐀𝐑 𝐀𝐍𝐌𝐂𝐎
𝐌𝐚𝐫𝐭𝐞𝐝𝐢̀ 𝟏𝟓 𝐚𝐩𝐫𝐢𝐥𝐞 𝟐𝟎𝟐𝟓 𝐨𝐫𝐞 𝟏𝟕.𝟎𝟎 - 𝟏𝟖.𝟑𝟎
"𝐀𝐍𝐌𝐂𝐎 𝐃𝐨𝐜𝐮𝐦𝐞𝐧𝐭𝐬: 𝐓𝐚𝐬𝐭𝐢𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧 - 𝐏𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐀𝐍𝐌𝐂𝐎 𝐬𝐮𝐥𝐥𝐚 𝐑𝐢𝐨𝐫𝐠𝐚𝐧𝐢𝐳𝐳𝐚𝐳𝐢𝐨𝐧𝐞 𝐟𝐮𝐧𝐳𝐢𝐨𝐧𝐚𝐥𝐞 𝐝𝐞𝐥𝐥𝐞 𝐔𝐓𝐈𝐂 𝐢𝐧 𝐈𝐭𝐚𝐥𝐢𝐚" 𝑎 𝑐𝑢𝑟𝑎 𝑑𝑒𝑙𝑙’𝐴𝑟𝑒𝑎 𝑀𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡&𝑄𝑢𝑎𝑙𝑖𝑡𝑎̀ #𝐴𝑁𝑀𝐶𝑂
𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐚 𝐢𝐥 𝐩𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐚 👇
https://anmco.it/pages/formazione/webinar/i-webinar-anmco/anmco-documents-tasting-collection-position-anmco-riorganizzazione-funzionale-utic-italia

06/03/2025

Indirizzo

Piazza Ospedale, 1
Treviso
31100

Telefono

+390422210703

Sito Web

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Dott. Nicola Gasparetto pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Dott. Nicola Gasparetto:

Condividi

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Digitare